Board meeting scheduled for May 19, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
Agenda includes consideration of final dividend recommendation and enabling resolution for fundraising through various equity instruments.
Trading window closed from April 1, 2026 to May 21, 2026 for insiders in compliance with SEBI insider trading regulations.